Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$38.9K Buy
25,786
+4,922
+24% +$9.4K ﹤0.01% 6510
2025
Q4
$44.9K Sell
20,864
-897
-4% -$3.06K ﹤0.01% 6472
2025
Q3
$105K Sell
21,761
-2,065
-9% -$11.3K ﹤0.01% 6126
2025
Q2
$132K Sell
23,826
-41,092
-63% -$325K ﹤0.01% 6028
2025
Q1
$797K Buy
64,918
+13,622
+27% +$208K ﹤0.01% 5113
2024
Q4
$687K Buy
51,296
+4,879
+11% +$55.5K ﹤0.01% 5285
2024
Q3
$435K Buy
46,417
+7,788
+20% +$78.8K ﹤0.01% 5465
2024
Q2
$375K Sell
38,629
-1,727
-4% -$17.1K ﹤0.01% 5422
2024
Q1
$424K Sell
40,356
-48,840
-55% -$604K ﹤0.01% 5387
2023
Q4
$1.19M Buy
89,196
+53,107
+147% +$726K ﹤0.01% 5219
2023
Q3
$523K Sell
36,089
-4,509
-11% -$77.6K ﹤0.01% 5147
2023
Q2
$800K Sell
40,598
-17,443
-30% -$274K ﹤0.01% 4962
2023
Q1
$945K Sell
58,041
-3,806
-6% -$58.8K ﹤0.01% 4896
2022
Q4
$646K Buy
61,847
+24,599
+66% +$218K ﹤0.01% 5104
2022
Q3
$199K Sell
37,248
-3,796
-9% -$28.6K ﹤0.01% 5729
2022
Q2
$367K Sell
41,044
-34,804
-46% -$405K ﹤0.01% 5578
2022
Q1
$1.34M Sell
75,848
-80,559
-52% -$2.51M ﹤0.01% 4793
2021
Q4
$8.89M Buy
156,407
+87,894
+128% +$5.87M ﹤0.01% 3071
2021
Q3
$5.17M Buy
68,513
+26,524
+63% +$2.81M ﹤0.01% 3654
2021
Q2
$7.06M Buy
41,989
+28,767
+218% +$5.04M ﹤0.01% 3408
2021
Q1
$2.32M Buy
13,222
+2,342
+22% +$472K ﹤0.01% 4135
2020
Q4
$2.23M Buy
10,880
+5,463
+101% +$1.01M ﹤0.01% 4054
2020
Q3
$1.06M Buy
+5,417
New +$1.3M ﹤0.01% 4179

Other funds holding GOCO

Morgan Stanley's GOCO Position: Q1 2026 in Review

Morgan Stanley increased its GoHealth (GOCO) stake by 24% in Q1 2026, buying an estimated $9.4K and bringing the position to 25,786 shares worth $38.9K. The position accounts for ﹤0.01% of the portfolio, ranked #6510.

Morgan Stanley first reported a position in GOCO in Q3 2020 and has held it in 23 quarters since. The position peaked at $8.89M in Q4 2021. 67 funds tracked by Wall St. Rank hold GOCO as of Q1 2026.

  • Morgan Stanley held 25,786 shares of GoHealth worth $38.9K as of Q1 2026.
  • Morgan Stanley bought 4,922 GoHealth shares in Q1 2026, an estimated $9.4K.
  • GoHealth made up ﹤0.01% of Morgan Stanley's portfolio in Q1 2026, its #6510 holding.
  • Morgan Stanley first reported a position in GoHealth in Q3 2020 and has held it in 23 quarters since.
  • Morgan Stanley's GoHealth position peaked at $8.89M in Q4 2021.
  • 67 funds tracked by Wall St. Rank held GoHealth as of Q1 2026.

Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.